Ketamidor 100 mg/ml - Injektionslösung für Tiere
Ketamidor 100 mg/ml - Injektionslösung für Tiere
Authorised
- Ketamine hydrochloride
Product identification
Medicine name:
Ketamidor 100 mg/ml - Injektionslösung für Tiere
Ketador Vet. 100 mg/ml injektionsvæske, opløsning
Active substance:
- Ketamine hydrochloride
Target species:
-
Dog
-
Cat
-
Pig
-
Cattle
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Ketamine hydrochloride115.33milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Dog
-
Cat
-
Pig
-
Meat and offal0day
-
-
-
Intravenous use
-
Cattle
-
Meat and offal0day
-
Milk0day
-
-
Dog
-
Horse
-
Meat and offal0day
-
Milk0day
-
-
Cat
-
-
Subcutaneous use
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Denmark
Available in:
-
Denmark
Package description:
- Clear glass vial, type I (Ph. Eur.) with bromobutyl-rubber stopper type I (Ph.Eur.) and aluminium cap, packed in a cardboard box. Package size: 1 x 10 ml
- Clear glass vial, type I (Ph. Eur.) with bromobutyl-rubber stopper type I (Ph.Eur.) and aluminium cap, packed in a cardboard box. Package size: 1 x 50 ml
- Clear glass vial, type I (Ph. Eur.) with bromobutyl-rubber stopper type I (Ph.Eur.) and aluminium cap, packed in a cardboard box. Package size: 5 x 10 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetviva Richter GmbH
Responsible authority:
- Danish Medicines Agency
Authorisation number:
- 49994
Date of authorisation status change:
Reference member state:
-
Austria
Procedure number:
- AT/V/0009/001
Concerned member states:
-
Belgium
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Netherlands
-
Poland
-
Portugal
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Danish (, INJEKTIONSVÆSKE, OPLØSNING 100 MG-ML)
Published on: 29/06/2023
How useful was this page?: